Literature DB >> 1520495

Localization of muscarinic receptor subtype mRNAs in human lung.

J C Mak1, J N Baraniuk, P J Barnes.   

Abstract

m2 mRNA in airway smooth muscle; m3 mRNA in airway epithelium, airway smooth muscle, and submucosal glands. No detection of m4 and m5 mRNAs was observed in any cellular structures. The presence of various muscarinic receptor subtype mRNAs was confirmed by Northern blot analysis. Only human lung mRNA hybridized to the m1 probe giving a single 3.2 kb transcript. mRNA from the human cultured airway smooth muscle cells gave m2 and m3 hybridization bands of about 6.0 kb and 4.5 kb, respectively, while mRNA from the cultured airway epithelial cells gave only m3 hybridization band of 4.5 kb. With the exception of the airway epithelium, there was a good correlation between the distribution of mRNAs by in situ hybridization and the distribution of receptor subtypes by autoradiographic mapping. These results may have an important clinical implication, and also give rise to further investigation of gene regulation of pulmonary muscarinic receptor subtypes in health and disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520495     DOI: 10.1165/ajrcmb/7.3.344

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  20 in total

1.  Luminal cholinergic signalling in airway lining fluid: a novel mechanism for activating chloride secretion via Ca²⁺-dependent Cl⁻ and K⁺ channels.

Authors:  Monika I Hollenhorst; Katrin S Lips; Miriam Wolff; Jürgen Wess; Stefanie Gerbig; Zoltan Takats; Wolfgang Kummer; Martin Fronius
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways.

Authors:  T Ikeda; A S M Anisuzzaman; H Yoshiki; M Sasaki; T Koshiji; J Uwada; A Nishimune; H Itoh; I Muramatsu
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 3.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

4.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

5.  Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.

Authors:  E B Haddad; H Patel; J E Keeling; M H Yacoub; P J Barnes; M G Belvisi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

6.  Characterization of the anatomical structures involved in the contractile response of the rat lung periphery.

Authors:  F G Salerno; H Kurosawa; D H Eidelman; M S Ludwig
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 7.  Muscarinic receptor agonists and antagonists: effects on cancer.

Authors:  Eliot R Spindel
Journal:  Handb Exp Pharmacol       Date:  2012

8.  CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.

Authors:  Silvia Jiménez-Morales; Juan Luis Jiménez-Ruíz; Blanca Estela Del Río-Navarro; Efraín Navarro-Olivos; Guillermo Escamilla-Guerrero; Ram Savan; Michael Dean; Lorena Orozco
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

9.  Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development.

Authors:  M K Klein; R V Haberberger; P Hartmann; P Faulhammer; K S Lips; B Krain; J Wess; W Kummer; P König
Journal:  Eur Respir J       Date:  2009-02-12       Impact factor: 16.671

10.  Isolated porcine bronchi provide a reliable model for development of bronchodilator anti-muscarinic agents for human use.

Authors:  G D'Agostino; A M Condino; L Gioglio; F Zonta; M Tonini; A Barbieri
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.